Latest total assets for LUCD: $34M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Lucid Diagnostics (LUCD) currently reports a total assets of $34M as of March 2026. That compares with $33B in the prior-year period — down 99.9% year over year. Use the charts on this page to explore Lucid Diagnostics's total assets history and peer comparisons.
Lucid Diagnostics's total assets decreased from $33B to $34M — a 99.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Lucid Diagnostics reported $34M in total assets as of March 2026. That compares with $33B in the prior-year period — down 99.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $34M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lucid Diagnostics, and consider following LUCD for alerts when major investors trade the stock.